Drugs Made In America Acquisition II has the GF Score of 15, which implies that the company
might have
Worst future performance potential, or not enough data.
The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.
GF Score takes following five key aspects into consideration:
Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.
Based on research and backtesting result, GuruFocus believes Drugs Made In America Acquisition II
might have
Worst future performance potential, or not enough data.
Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.
Drugs Made In America Acquisition II (NAS:DMII) GF Score Explanation
Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:
GF Score
Performance Potential and All-in-One Screener Examples (1)
(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.
Drugs Made In America Acquisition II GF Score Related Terms
DMII vs BCSS, EVAC, CEPF: GF Score Comparison
For the Shell Companies subindustry, Drugs Made In America Acquisition II's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Drugs Made In America Acquisition II GF Score vs Diversified Financial Services Industry
For the Diversified Financial Services industry and Financial Services sector, Drugs Made In America Acquisition II's GF Score distribution charts can be found below:
* The bar in red indicates where Drugs Made In America Acquisition II's GF Score falls into.
Drugs Made In America Acquisition II (DMII) has a GF Score of 15 as of Jul. 11, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Drugs Made In America Acquisition II and its competitors. This is 32% below median its historical median of 22.00. Over the past decade, Drugs Made In America Acquisition II's GF Score has ranged from 15.00 to 22.00.
Is Drugs Made In America Acquisition II's GF Score too high?
Drugs Made In America Acquisition II's current GF Score of 15 is 32% below median its 10-year median of 22.00. Over the past 10 years, this metric has ranged from a low of 15.00 to a high of 22.00. Overall, Drugs Made In America Acquisition II has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Drugs Made In America Acquisition II's GF Score compare to BCSS and EVAC?
Drugs Made In America Acquisition II's GF Score of 15 can be compared against companies in the Diversified Financial Services industry. Historically, Drugs Made In America Acquisition II's own GF Score has ranged from 15.00 to 22.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Diversified Financial Services company?
A good GF Score depends on the Diversified Financial Services industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Drugs Made In America Acquisition II and its competitors. Drugs Made In America Acquisition II's current GF Score is 15, which is 32% below median its own 10-year median of 22.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Drugs Made In America Acquisition II stock overvalued right now?
Drugs Made In America Acquisition II (DMII) has a current GF Score of 15. The current GF Score is 15, which is 32% below median its 10-year median of 22.00. Drugs Made In America Acquisition II's overall GF Score™ is 15/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Drugs Made In America Acquisition II (DMII), the current GF Score is 15 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Drugs Made In America Acquisition II Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DMII has been successfully added to your 